Skip to main content
U.S. flag

An official website of the United States government

This site is currently in beta, and your feedback is helping shape its ongoing development.

Guanfacine hydrochloride

Published by U.S. Food and Drug Administration | U.S. Department of Health & Human Services | Metadata Last Checked: February 18, 2026 | Last Modified: 2025-03-17
Guanfacine Hydrochloride is a generic prescription medication available as oral tablets in 1mg and 2mg strengths. It acts as a central alpha-2 adrenergic agonist, commonly used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents, and sometimes for high blood pressure in adults. Manufactured by Xiromed, LLC, under application ANDA218326. This information was generated using AI and is provided for informational and research purposes only.

Find Related Datasets

Click any tag below to search for similar datasets

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov